Hutchison China MediTech Ltd. Company Profile | StatInvestor

Health Care & Life Sciences » Pharmaceuticals | Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd.

Hutchison China MediTech Ltd.
Stock Exchange	London Stock Exchange
EPS	GBP0.08
Market Cap	GBP2.45 B
Shares Outstanding	666.58 M
Public Float	21.83 M

Hutchison China MediTech Ltd. ADR
Stock Exchange	NASDAQ Stock Market
EPS	$0.06
Market Cap	$30.09 B
Shares Outstanding	133.32 M
Public Float	-

Profile

Address	Cheung Kong Center Hong Kong Hong Kong
Employees	-
Website	http://www.chi-med.com
Updated	07/08/2019
Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products. It operates through the Innovation Platform and Commercial Platform segments. The Innovation Platform segment relates to research and development of innovative therapeutics in oncology and autoimmune diseases.

Financials

Chi Keung To

Chairman

Christian Hogg

Chief Executive Officer & Executive Director